Page last updated: 2024-09-05

tetraphenylphosphonium and Ovarian Neoplasms

tetraphenylphosphonium has been researched along with Ovarian Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Albright, KD; Andrews, PA1
Andrews, PA; Zinkewich-PĂ©otti, K1

Other Studies

2 other study(ies) available for tetraphenylphosphonium and Ovarian Neoplasms

ArticleYear
Mitochondrial defects in cis-diamminedichloroplatinum(II)-resistant human ovarian carcinoma cells.
    Cancer research, 1992, Apr-01, Volume: 52, Issue:7

    Topics: Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cell Line; Cell Membrane; Cisplatin; Drug Resistance; Female; Fluorescent Dyes; Humans; Kinetics; Membrane Potentials; Microscopy, Electron; Microscopy, Fluorescence; Mitochondria; Nigericin; Onium Compounds; Organophosphorus Compounds; Ovarian Neoplasms; Rhodamine 123; Rhodamines

1992
Loss of cis-diamminedichloroplatinum(II) resistance in human ovarian carcinoma cells selected for rhodamine 123 resistance.
    Cancer research, 1992, Apr-01, Volume: 52, Issue:7

    Topics: Cadmium; Cadmium Chloride; Cell Line; Cisplatin; Doxorubicin; Drug Resistance; Female; Flow Cytometry; Fluorescent Dyes; Glutathione; Humans; Kinetics; Onium Compounds; Organophosphorus Compounds; Ovarian Neoplasms; Rhodamine 123; Rhodamines

1992